Chronic myelogenous leukemia: A review and update of therapeutic strategies

This publication has 171 references indexed in Scilit:

• Population-Based Age- and Sex-Specific Incidence Rates in the 4 Main Types of Leukaemia
  Scandinavian Journal of Haematology, 2009
• Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
  Blood, 2003
• Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
  New England Journal of Medicine, 2003
• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
  New England Journal of Medicine, 2002
• Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
  New England Journal of Medicine, 2001
• Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL
  The Journal of Experimental Medicine, 2000
• Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
  New England Journal of Medicine, 1998
• Induction of interferon regulatory factors, 2′‐5′ oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness
  British Journal of Haematology, 1996
• The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
  New England Journal of Medicine, 1988
• Characteristics of accelerated disease in chronic myelogenous leukemia
  Cancer, 1988